908 Devices Inc (MASS)

24.00 +0.62  +2.65% NASDAQ Nov 30, 16:00 24.50 +0.50  +2.08% Pre-Market: 08:24 USD

908 Devices Cash from Financing (TTM):

137.38M for Sept. 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 137.38M
June 30, 2021 136.90M
   
March 31, 2021 136.62M
Dec. 31, 2020 137.19M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Xtant Medical Holdings Inc 16.81M
Asensus Surgical Inc 169.08M
Ra Medical Systems Inc 14.49M

Cash from Financing (TTM) Range, Past 5 Years

Minimum 136.62M Mar 2021
Maximum 137.38M Sep 2021
Average 137.02M

News

Insider Sell: 908 Devices
MT Newswires 11/05 16:55 ET
Insider Sell: 908 Devices
MT Newswires 11/02 17:24 ET
Insider Sell: 908 Devices
MT Newswires 10/19 16:53 ET
Insider Sell: 908 Devices
MT Newswires 10/07 16:59 ET
Insider Sell: 908 Devices
MT Newswires 09/17 16:47 ET
Insider Sell: 908 Devices
MT Newswires 09/10 16:33 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.